Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Phase 3 switch study of S-8117 (OTR) vs oxycodone CR in chronic pain
jRCT2080223929Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of S-8117 in chronic low back pain (CLBP), osteoarthritis (OA), diabetic neuropathy and 2 more, sponsored by Shionogi & Co., Ltd. Primary endpoints: Efficacy after switching vs before switching and Safety after switching vs before switching. Started Jun 2018; status: completed.
02
Drugs
S-8117
03
Conditions
chronic low back pain (CLBP)osteoarthritis (OA)diabetic neuropathypostherpetic neuralgia (PHN)chronic pain
Beyond the preview
Go deeper on jRCT2080223929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223929.